NoSpin HepaRG cells (Biopredic International, or equal)
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 75F40124SSN123012
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services (HHS), Food and Drug Administration (FDA), is seeking to procure Biopredic International, or equal, NoSpin HepaRG cells. These cells will be used by the National Center for Toxicological Research (NCTR) to conduct research on the cytotoxicity and genotoxicity of over 30 small-molecule nitrosamines and nitrosamine drug substances-related impurities. The key requirements are that the cells must be fully differentiated, supplied in a format that does not require centrifugation and counting following thaw, and each ampule/vial must contain 8.0 million cells at >90% viability. Responses must be submitted by April 24, 2024, and must provide company information, past performance, technical details, and pricing.
This is a market research effort, not a solicitation, and no contract will be awarded from this announcement. There is no set-aside designation, and the applicable NAICS code is likely 325413 (In-Vitro Diagnostic Substance Manufacturing). The FDA is encouraging responses from small businesses, especially those that can offer domestic products, as well as other than small business concerns that can meet the stated requirements. No potential incumbents or current contractors are named, and no award value or budget range is provided.
Notice text
See attached Sources Sought Notice (SSN) for Biopredic International, or equal, NoSpin HepaRG cells.
Small business concerns, Other than small business concerns, and especially vendors who may be able to offer domestic products, are all encouraged to submit a capability statement that provides company information, as well as information demonstrating that it can meet all of the minimum requirements included in the SSN, to include the country of manufacture of products offered.
Files
| File | Type | Posted |
|---|---|---|
| SSN 75F40124SSN123012.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Biopredic International NoSpin HepaRG cells, or equal | Solicitation | |
| This notice | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity